Journal of Clinical Psychiatry
Publication Venue For
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)
Efficacy of ziprasidone augmentation of escitalopram for cognitive symptoms of major depressive disorder
Clinical and genetic predictors of delayed remission after multiple levels of antidepressant treatment: Toward early identification of depressed individuals for advanced care options
Ziprasidone augmentation of escitalopram for major depressive disorder: Cardiac, endocrine, metabolic, and motoric effects in a randomized, double-blind, placebo-controlled study
Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled Acute Study
Baseline disability and poor functioning in Bipolar disorder predict worse outcomes: Results from the Bipolar CHOICE study
Bipolar CHOICE (clinical health outcomes initiative in comparative effectiveness): A pragmatic 6-month trial of lithium versus quetiapine for Bipolar disorder
Association of obesity and inflammatory marker levels on treatment outcome: Results from a double-blind, randomized study of adjunctive l-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs
MDDScore: Confirmation of a blood test to aid in the diagnosis of major depressive disorder
Reply to commentary by rothschild: "A blood test for depression?"
What are the comparative benefits and harms of augmentation treatments in major depression?
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder
Using moderator-based algorithms and electronic medical records to achieve optimal outcomes in depression.
Challenges and algorithm-guided treatment in major depressive disorder.
Crisis of confidence: antidepressant risk versus benefit.
A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression
Evidence for the use of l-methylfolate combined with antidepressants in MDD.
Moderators of antidepressant response in major depression.
Performance improvement CME: algorithms and EMRs in depression.
Using algorithms and computerized decision support systems to treat major depression.
St John's wort (Hypericum perforatum) in major depression
Long-term management of depression: Tips for adjusting the treatment plan as the patient's needs change
Family history of depression and therapeutic outcome: Findings from STAR*D
Pathophysiologic mechanisms of fibromyalgia and its related disorders
Do Atypical Antipsychotics Effectively Treat Co-Occurring Bipolar Disorder and Stimulant Dependence?
Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial
Evaluating and diagnosing fibromyalgia and comorbid psychiatric disorders.
Multidisciplinary care and stepwise treatment for fibromyalgia.
The history and current state of antidepressant clinical trial design: A call to action for proof-of-concept studies
Augmentation strategies to increase antidepressant efficacy
Dr. Shelton replies 
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: Outcomes from the 2-year and combined maintenance phases
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: A randomized, open-label, pilot study
A pharmacokinetic and clinical evaluation of switching patients with bipolar I disorder from delayed-release to extended-release divalproex
Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: A meta-analysis
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT study
Use of treatment algorithms for depression
Antidepressant discontinuation syndrome: Consensus panel recommendations for clinical management and additional research
The nature of the discontinuation syndrome associated with antidepressant drugs
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder
Olanzapine/fluoxetine combination for treatment-resistant depression: A controlled study of SSRI and nortriptyline resistance
Psychiatric genetics: A survey of psychiatrists' knowledge, opinions, and practice patterns
Risperidone and paroxetine given singly and in combination for bipolar depression
The dual-action hypothesis: Does pharmacology matter?
The effectiveness of St. John's wort in major depressive disorder: A naturalistic phase 2 follow-up in which nonresponders were provided alternate medication
Risperidone in the treatment of delirium: Results from a prospective open-label trial
The use of antidepressants in novel combination therapies
Mechanisms of action in the treatment of anxiety
Introduction: Remission of anxiety-related disorders
Measuring patient symptom change on rural psychiatry units: Utility of the symptom checklist-90 revised
Mood-stabilizing drugs in depression
Treatment options for refractory depression
The distribution of body mass index among individuals with and without schizophrenia
Update on the management of bipolar illness
The undertreatment of dysthymia
Fluoxetine in dementia of the Alzheimer's type: Prominent adverse effects and failure to improve cognition 
The effects of race and comorbidity on clinical diagnosis in patients with psychosis
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)